Gene Therapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Gene Therapy
New gene therapy study findings have been published by scientists at University of Illinois
December 18th, 2008
According to recent research from the United States, "SLC26A6 (putative anion transporter 1, PAT1) has been shown to play an important role in mediating the luminal Cl-/OH-(HCO3-)exchange process in the intestine. Very little is known about the molecular mechanisms involved in the transcriptional regulation of intestinal SLC26A6 gene expression in the intestine." "Current studies were, therefore, designed to clone and characterize the 5'-regulatory region of the human SLC26A6 gene and determine the mechanisms involved in its regulation. A 1,120 bp (p-964/+156) SLC26A6 promoter fragment cloned upstream to the luciferase reporter gene in pGL2-basic exhibited high promoter...
Source: Gene Therapy Weekly (2008-12-18)
|
